000 | 01514 a2200421 4500 | ||
---|---|---|---|
005 | 20250515112633.0 | ||
264 | 0 | _c20080619 | |
008 | 200806s 0 0 eng d | ||
022 | _a1540-658X | ||
024 | 7 |
_a10.1089/adt.2007.099 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPatel, Rupal | |
245 | 0 | 0 |
_aATLAS--a high-throughput affinity-based screening technology for soluble proteins: technology application using p38 MAP kinase. _h[electronic resource] |
260 |
_bAssay and drug development technologies _cFeb 2008 |
||
300 |
_a55-68 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xchemistry |
650 | 0 | 4 | _aBiophysical Phenomena |
650 | 0 | 4 | _aBiophysics |
650 | 0 | 4 | _aCircular Dichroism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
650 | 0 | 4 | _aHot Temperature |
650 | 0 | 4 |
_aLuciferases _xantagonists & inhibitors |
650 | 0 | 4 | _aProtein Denaturation |
650 | 0 | 4 | _aProtein Folding |
650 | 0 | 4 | _aTemperature |
650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
700 | 1 | _aLebrun, Laurie A | |
700 | 1 | _aWang, Shaohui | |
700 | 1 | _aHowett, Lindsay J | |
700 | 1 | _aThompson, Peggy A | |
700 | 1 | _aAppleman, James R | |
700 | 1 | _aLi, Bin | |
773 | 0 |
_tAssay and drug development technologies _gvol. 6 _gno. 1 _gp. 55-68 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/adt.2007.099 _zAvailable from publisher's website |
999 |
_c17837964 _d17837964 |